Britain Will Be First To Offer Nationwide Meningitis B Vaccination Program The UK announced an agreement with drug company GSK over the costs of the vaccine for MenB. The nationwide vaccination program could begin in September. by Jim Algar
Healthy Living/Wellness Novartis submits application for marketing approval of Bexsero meningitis B vaccine by Anne Francis